Report
Debbie Wang
EUR 850.00 For Business Accounts Only

Morningstar | Quest Diagnostics Leans on Its Narrow Moat to Weather Medicare Reimbursement Pressure

Quest Diagnostics has positioned itself as the leading provider of independent diagnostic testing in the U.S. by building out a network of more than 2,000 patient service centers across the country. We think Quest's size and cost advantage will allow it to benefit from several secular trends, including the proliferation diagnostic tests and greater clinical reliance on personalized therapies. Additionally, we expect that over the longer term, reimbursement pressure will push hospital-based labs and small independents to outsource more volume at the largest, lowest-cost producers, including Quest.Quest and its primary national competitor, LabCorp, dominate the independent diagnostic testing landscape. Thanks to vast national networks of laboratories, the two firms have created barriers to entry and generated substantial cost advantages over regional and hospital labs. The industry has seen steady consolidation, as both companies have acquired smaller competitors. Most recently, Quest has focused on establishing a presence in hospital-based labs, either on an operational or consulting basis. This is in contrast with its historical pattern of expanding its portfolio of higher-margin esoteric tests with the acquisitions of AmeriPath, Athena, and Celera.Importantly, Quest has benefited from key trends including greater activism by managed care to steer insureds to the lower-cost labs, the penetration of high-deductible plans, and increased presence in retail.Despite Quest's formidable size and attractive cost structure, the firm has historically trailed peer LabCorp on operational efficiency in its diagnostics business. We think the firm's recent shift toward working with hospital-based labs could hamper efficiency even further due to the higher cost structure of the latter. Nonetheless, Quest still reliably generates economic profits, which underscores the strength of its moat. The current management team spent the four years focused on ongoing integration of its acquisitions, playing catch-up on the operations front, and streamlining the organization for greater efficiency. We have finally begun to see results from this turnaround effort on profitability growth.
Underlying
Quest Diagnostics Incorporated

Quest Diagnostics provides diagnostic information services. The company's diagnostic information segment provides information based on the menu of routine, non-routine and clinical testing and anatomic pathology testing, and other diagnostic information services. The company's testing capabilities, includes services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and provides tests in several fields, including endocrinology, immunology, neurology and oncology. The company's diagnostic solutions provides risk assessment services for the life insurance industry, as well as provides healthcare organizations and clinicians health information technology solutions.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch